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The amino acid composition of transmemhrane proteins was analyzed for their three separate portions: the transmembrane apolar, cytoplasmic 
and extracellular egions. The composition was different between cytoplasmic and extracellular peptides; alanine and argininc residues were 
preferentially sited on the cytoplasmic side, while the threonine and cysteinc/cysdne were preferentially sited on the extracellular side, The 
composition ofcytoplasmic and extracellular peptides of membrane protcinscorresponded to those of intracellular and extracellular types ofsoluble 
proteins, respectively. This difference in composition was independent of the peptidc orientation against he membrane. Peptide chains could he 
correctly assigned as either cytoplasmic or cxtraccllular, solely from an analysis of sequence composition. For single-spanning membrane proteins 
the predictive accuracy was 9046, whereas for multi-spanning proteins this was 85%. 
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1. INTRODUCTION 
The analysis of an amino acid sequence is a simple 
and useful way to classify proteins into groups. Dayhoff 
[ 1] originally classified proteins into families or superfa- 
milies using standard alignment procedures and, more 
recently, about 8,000 proteins from the Protein Identifi- 
cation Resource (PIR) database [2] were classified into 
around 2,500 superfamilies. We have reported [3-61 that 
the character of a protein is also related to its amino 
acid composition and this varies with location (inside or 
outside of the cell), function (enzyme or non-enzyme) 
and folding type. The amino acid composition of an 
extracellular protein, which is characterized as having 
a signal peptide at the N-terminus, is different from that 
of intracellular proteins [4]. 
Here we have analyzed membrane proteins to see 
whether a difference in amino acid composition also 
occurs between cytoplasmic and extracellular portions. 
We initially focused our analysis on single-spanning 
membrane proteins because their chain constitution is 
simple, Furthermore, the location and orientation of the 
single transmembrane region can be determined with 
greater accuracy be experimental means than multi- 
spanning ones. The amino acid composition was ana- 
lyzed for three distinct regions: the cytoplasmic and 
extracellular domains, as well as the transmembrane 
segment. Those proteins which have reverse orienta- 
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tions to the membrane were also included in order to 
examine the effect of peptide chain directionality. A 
similar analysis was then applied to multi-spanning 
membrane proteins to ascertain whether the trends ob- 
served in single-spanning membrane proteins held true 
for all membrane proteins. 
2. MATERIALS AND METHODS 
2. I, Prorcin duru 
The 45 single-spanning and 24 multi-spanning membrane proteins 
were taken from release 27.0 of the PIR database [2]. The first 30 
single-spanning proteins listed in Table I have been classified into 
superfamilies [2], while the remainder have yet to be classified. Most 
are plasma membrane proteins such as hormone rcccptors or antigen 
proteins. Others are endoplasmic reticulum membrane proteins com- 
prising 38 from eukaryotea. 4 from prokaryotes and 3 from viruses. 
Only proteins with less than 25% residue identity were included in this 
analysis. Information on transmembranelocation a d orientation was 
obtained from the annotations of the PIR database or the literature 
cited in Table I. 
The classification of transmcmbrane proteins proposed by von 
Heijne and Gavel [7] was adopted. A type-l protein has a signal 
peptide for secretion, which is cleaved upon maturation. The N-termi- 
nus of the mature protein sits on the extracellular side, where ils 
C-terminus is in the cytoplasm. A type-11 protein has the opposite 
orientation to type I and no signal peptidc. A type-111 protein has the 
same orientation as type-l but has no cleavable signal peptide. In this 
work 32 type-t, 8 type-11 and 5 type-Ill proteins were used asexamples 
of singie-spanning membrane proteins (Table I). 
Multi-spanning transmembrdne proteins arc classified as type-IV 
[I. 24 exllmples are shown in the footnote of Table III together with 
their PIR codes. They comprise I8 eukaryotic, 4 prokaryotic and 2 
virus proteins. 
2.2. Culudarion of cotttpositiolt and distunce 
Since the amino acid composition of short peptides can vary signif- 
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icantly WC have exumined only those cytoplasmic and extracellular 
pcptides longer than 50 residues, excluding the cleavable signal pep- 
tide. In total, 73 peptidcs in single-spanning proteins and 54 pcptidcs 
in multi-spanning proteins were used. The number of residues in each 
cytoplasmic and extracellular domain examined is shown in the col- 
umns of N,,, and N,,, in Table 1. 
A protein or peptide can bc represented as one point in amino acid 
composition space 13-61. Two proteins (or peptides) are compared by 
measuring the distance between them. The normalized composition is 
defined as CAi = A,ISD,, where A, is the content (in percentage) of
amino acid type-i and SDi is the standard deviation over a large set 
of proteins, The distance betwceu two peptidcs, j and k, is thus given 
by: 
nj, = [$i (CAij - CAik)‘]’ 
The average composition (/I l’i) and standard eviation (SDi) listed in 
Table II wcrc calculated using a large number of proteins [6J. 
3. RESULTS AND DISCUSSION 
The average amino acid composition of the cytoplas- 
Tablc I 
45 single-spanning trtmsmembrane proteins listed with their PIR codes 
1 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
12 
13 
14 
IS 
I6 
I7 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
;: 
ss 
34 
35 
35 
37 
38 
39 
40 
41 
42 
43 
44 
45 
URXLA2 
RDRTO4 
*GQHUE 
NMI‘V 
LWECB 
PWRYNB 
OYURGA 
*QRHULD 
*GQHUN 
UHHLJI, 
*QRRBG 
l BNRT3 
TDRTOX 
RWHUC2 
HLHUDA 
HLHUG 
RWHUDI 
*TDRTLT 
SAHUBF 
QRHUA4 
MPRTO 
LNHU2A 
GFHUE 
l NBHUIA 
IJHULM 
JXHU 
“TFHUM 
QRECS 
*HNVZVV 
MMIV’ 
A25970 
A22841 
*SO0670 
so3900 
A31932 
A30342 
A2616& 
B26168 
so4530 
*A26396 
A27068 
*A30788 
‘SO5479 
A27410 
A25742 
Alpha-antidating enzyme II - African clawed frog 
NADPH cytochrome P-450 rcductesc - Rat 
Epidermal growth factor receptor - Human 
Sialidase - Influenza A virus 
H’-transporting ATP synthasc b chain - fkhviclriu coli 
Na’, K+-transporting ATPase beta chain - Electric ray 
Guanylatc cyclasc - Sea urchin 
LDL receptor - Human 
Nerve growth Factor receptor - Human 
Interleukin-2 receptor - Human 
Poly-Ig receptor - Rabbit 
Myclin-associated glycoprotein, long form - Rat 
OX.2 membrane glycoprotcin - Rat 
T-cell surface glycoprodn CD2 - Human 
Class II histocompatibility antigen alpha chain - Human 
Class I1 histucompatibility antigen gamma chain - Human 
T-cell surface plycoprotein CD3 delta chain - Human 
Leukocyte common antigen - Rut (fragment) 
Cell surface antigen 4F2 heavy chain - Human 
Alzheimer’s disease amyloid A4 proiein - Human 
Myelin PO protein - Rut 
Hepatic lectin H2a - Human 
Glycophorin A - Human 
Platelet glycoprotein Ib alpha chain - Human 
Leukocyte adhesion protein beta chain - Human 
Transferrin receptor - Human 
Melanotransferrin - Human 
Serine chemoreceptor p otein - EscIwricIlkt cm/i 
Hemagglutinin - Vaccinia virus 
Matrix (M2) protein - Inftuenza A virus 
Transcriptional activator protein - Yihriu &&~IL~ 
Reaction center H chain - Hl?or~u~,snrrlr,r,ru,rrrs vi~ir/i,s 
Gene Delta protein - Fruit fly 
Gene torso protein - Fruit fly 
IgG PC receptor - Human 
Inrerleukin-2 receptor beta chain - Human 
Ribophorin I - Human 
Ribophorin II - Human 
Somatotropin receptor, hepatic - Human 
T-cell surface glycoprotcin CD5 - Human 
Cation-dependent mannose 6-phosphate r ceptor - Bovine 
Cation-independent mannose 6.phosphate receptor - Bovine 
Neural cell adhesion tnolcculc - Mouse 
Plasma ccl! membrane protein - Mouse 
Platclet~derived growth fuctor receptor - Mouse 
88 
634 
542** 
130 
458 
50** 
IS5 
103 
90 
I IS 
70s 
81 
69 
SE 
96 
61 
323 
54 
182 
223 
261 
503 
76 
286 
150 
705” 
350 
93 
67 
163 
114 
58 
542 
724 8 
9, IO 
621 
414 II 
12 
242 I3 
478 
767 
222 
219 
629 
494 
202 
182 
191 
I60”* 
79 
425” 
bO7*’ 
124 
233 
72 
485 
678 
671 
694 
ISI*+ I4 
259 
15 
96 16 
I7 
572 18 
379 19 
178 20 
214 21 
416 22 
s17 22 
246 23 
347 24 
165 25 
2269 26 
1104 27 
826 28 
499 29 
‘Type’ indicates the type of membrane protein as defined by van Heijne and Gavel [7]. ‘N,,’ and ‘N,,,’ ’ tndicatc the number of residues of a peptide 
on the cytoplasmic and extracellular sides, rcspcctively. Those peptidcs of less than 50 residues long which were not used in the analysis are left 
blank. Proteins marked with * before the code contain duplication in their sequences. Peptides marked with ** are those which failed tire assigunent 
based on the composition data. 
142 
Volume 303, number 2,3 FEBS 
mic (CYT), extracellular (EXT) and apolar membrane 
(MEM) regions of single-spanning membrane proteins 
are shown in Table Il. These were calculated using 33, 
40 and 45 proteins, respectively (Table I). Compared to 
the average (AV) composition calculated from proteins 
of the PIR database [6], the content of hydrophobic 
residues was low and that of hydrophilic residues was 
high for both cytoplasmic and extracellular egions. 
This is because the average calculated from the PIR 
database includes a considerable number of proteins . 
with transmembrane r gions, whereas our cytoplasmic 
and extracellular peptides are without them. The trans- 
membrane region was rich in hydrophobic residues uch 
as Leu, He, and Val (the three letter nomenclature for 
amino acids is used hereafter), and this was similar to 
other analyses [6,7,30,31]. 
Table II shows deviation in the amino acid composi- 
tion between the CYT and EXT regions. It is interesting 
to note that a-helix-favoring residues [32,33] such as 
Glu, Met, Ala and Leu are more frequently observed in 
the peptide on the cytoplasmic side, whilej?-sheet-favor- 
ing residues 132,331, such as Val, Ile, Phe and Tyr, are 
more frequently found on the extracellular side. 
Charged residues, both basic (Arg, Lys) and acidic 
Table II 
Average amino acid compositions (%) of cytoplasmic (CYT), extracel- 
lular (EXT) and membrane (MEM) regions of singic-spanning trans- 
membrane proteins 
Amino CYT (CYFZ) 
acid 
EXT (EXTI) MEM AV SD 
Ala 8.63 (10.88) 
CYS 1.03 (0.69) 
Asp 6,24 (6.13) 
Glu 1.82 (9.34) 
Phc 2,?3 (2,93) 
GlY 6,tO (7.72) 
His 2.70 (2.15) 
Ile 3.48 (1.80) 
LYS 6.25 (6.1 I) 
Leu 8.44 (8.03) 
Met 2.14 (3.79) 
Asn 4.18 (5.75) 
Pro 6.28 (7.21) 
Gill 4.76 (4.68) 
Arg 6.75 (6.01) 
Set- 8.53 (7.25) 
Thr 4.43 (3.51) 
Val 5.44 (4.57) 
Trp 0,80 (0.47) 
Tyr 2s4 (1.01) 
No. of 33 5 
pcptides 
5.15 (5.04) 
3.24 (2.20) 
5.75 (5.26) 
7.05 (6.07) 
3052 (3.72) 
6.38 (7.09) 
2.69 (2.99) 
4.40 (4.32) 
5,25 (6.3 I) 
8.11 (9.88) 
1.60 (1.85) 
4.81 (5.94) 
5.65 (6.22) 
4.45 (4.50) 
4.38 (3.73) 
z 
(8.05) 
7:oo 
(5.20) 
(6.19) 
I .68 (2.10) 
3.42 (3.32) 
40 8 
9.90 8.0 3.7 
2.55 1.8 2.3 
0.35 5.1 2.2 
0.08 6.1 3.0 
6047 3.8 1.9 
8.14 6.9 3.4 
0.20 2.2 1.6 
15.25 5.5 2.5 
0.16 6.0 3.4 
22.28 902 3.4 
1.85 2.5 1,4 
0.94 4.3 2.3 
2.38 5.0 3.2 
0.87 4.0 2.4 
0.09 5.9 3.3 
4.17 6.8 2.8 
4.33 5.8 2.6 
14.34 6.7 2.5 
2.21 1.3 1.2 
3.42 3.2 1.8 
45 
C./T2 and EXT2 indicate composition of type-11 proteins. The total 
number of peptides used in the estimation is indicated in the bottom 
row. ijokro acid composition -*as cstimatcd for individual pcptidcs 
and then the average was calculaled over all the peptides considered. 
AV and SD stand for averngc and standard deviation obtained from 
a large number of proteins 161. 
LETTERS June 1992 
0.0 
ARMK5DP5GGLHNlFYVWCT 
Amino acid 
Fig. 1. Average amino acid composition of the cytoplasmic (in open 
bars) and extracellular domains (in dotted bars) of single-spanning 
transmembranc proteins. The difference calculated as (cytoplasmic- 
cxtracellular)/(standard deviation) is plotted with filled circks. 
(Glu, Asp) are prefenntially sited on the cytoplasmic 
side whereas aromatic residues (Trp, Tyr, Phe) are pref- 
erentially found on the extracellular side. For histidine, 
which is aromatic in terms of character and charge, 
there is no preference, 
In order to show the deviation more clearly we calcu- 
lated the difference defined as (CYT-EXT)/SD. The 
composition of both cytoplasmic and extracellular pep- 
tides are plotted in Fig. 1 in decreasing order of differ- 
ence (CYT-EXT). As shown in Fig. I, the siting of Ala 
and Arg residues hows a strong preference for the cyto- 
plasmic side, while that for Thr, Cys and Trp residues 
shows a preference for the extracellular side. A similar 
deviation in amino acid content was observed between 
intracellular and extracellular types of soluble proteins 
[41* 
The compositions of type-11 membrane proteins, 
which have the reverse orientation, are shown sepa- 
rately in columns CYT2 and EXT2 of Table Il. The 
average composition of type-11 proteins does not differ 
significantly from those of cytoplasmic and extraeellu- 
lar peptides, indicating that the difference in the amino 
acid composition is independent of peptide orientation. 
Next the deviation of amino acid content was exam- 
ined for 28 single-spanning proteins that have peptides 
of more than 50 residues on both sides of the membrane 
(see Table I). For 22 of these proteins, Ala was more 
frequently found on the cytoplasmic side. Conversely, 
in 25 of the 28 proteins, Thr was found preferentially 
on the extracellular side. The deviation of amino acids 
was correlated with the average composition of peptide 
chains on the cytoplasmic and extracellular sides. 
Each peptide in Table I (33 cytoplasmic and 40 ex- 
traccllular) was characterized using the distance in com- 
position space. Distances for a given peptide to the 
points defined by the average compositions of CYT and 
EXT (Table Il) were used to ciassify each peptide de- 
pending on which had the shorter distance. For in- 
stance, in the first protein in Table I, URXLM, the 
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cytoplasmic peptide (88 residues) has distances of 5.53 
and 6.09 to the average points of CYT and EXT. respec- 
tively. Thus, it is classified as CYT type because of the 
shorter distance to CYT. In other words, the peptidc 
has a composition typical of a cytoplasmic peptide. The 
extracellular peptide (724 residues) of the same protein 
is also typical, having a closer distance to EXT. The set 
of distances in this case are CYT=2.88 and EXT=2.27. 
In this way, all the peptides of single-spanning proteins 
were examined and the results showed that 90% (66173) 
of them have typical compositions. In other words, they 
can be correctly assigned as either of CYT or EXT types 
from their amino acid composition. Peptides incorrectly 
assigned are marked in Table I. It should be noted that 
the success was similar for type-11 proteins where 11 
peptides out of 13 (85%) were correctly assigned. This 
reinforces the previous statement and suggests that the 
characteristic composition of each domain is independ- 
ent of the transmembrane topology. 
The analysis was repeated for 24 multi-spanning 
membrane proteins. Average compositions for 34 cyto- 
plasmic and 20 extracellular peptides (longer than 50 
residues) are shown in Table III. The average composi- 
tion of multi-spanning proteins does not differ signifi- 
cantly from those of single-spanning proteins (Table II). 
The assignment with distance in composition space was 
also applied to show that distinction between cytoplas- 
mic or extracellular sides could successfully be made. 
For multi-spanning proteins an accuracy of 85% (46154) 
was observed. These data indicate that the trend found 
in single-spanning proteins generally holds for mem- 
brane proteins, including those with long connecting 
loops between transmembrane s gments, 
Since the three-dimensional structures for proteins in 
Table I are not available, except for the photosynthetic 
reaction center H chain [ 171, the locations of transmem- 
brane regions are not certain. Consequently we fol- 
lowed the authors’ assignments given in the literature. 
In the present study, however, we are concerned with 
the amino acid composition of cytoplasmic and ex- 
tracellular peptides composed of at least 50 residues, so 
deficiencies in the assignment of transmembrane re- 
gions should not affect the results significantly. The 
number of membrane proteins available from prokar- 
yotes and viruses are not large enough to draw any firm 
conclusions. Some of the proteins in Table I contain 
duplicated sequences of longer than 50 residues, such as 
the LDL receptor which has repeated sequences of the 
EGF-like module [35]. We checked whether the amino 
acid composition might be biased towards duplication, 
and found that the average composition for 13 proteins 
with duplications did not differ significantly from the 
others in either the cytoplasmic or extracellular pep- 
tides. 
It is known that carbohydrate attachment by N-gly- 
cosidic linkage occurs at Asn-X-&r or Asn-X-Thr sites 
on the extracellular side. Since 82% (37/45) of single- 
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spanning proteins used here were glycoproteins. the 
content of Asn, Ser and Thr residues had been expected 
to be higher in the extracellular side than in the cyto- 
plasm. However, on the extracellular side the content of 
Asn was not as high as that of Thr, and Ser was found 
Table III 
Average amino acid compositions (%) ofcytoplasmic (CYT), extracel- 
lular (EXT) and membrane (MEM) regions for 24 multi-spanning 
transmembrane proteins. 
Amino acid CYT EXT MEM 
Ahl 6.69 5.08 9.36 
Cys 1.70 2.95 2.56 
Asp 4.97 5.96 0.94 
GlU 7.76 6.04 0.94 
Phc 3.59 4.36 10.99 
ClY 6.23 8.20 6.17 
His 2.11 2.10 0.47 
Be 4.51 4.95 13.73 
Lys 8.36 4.93 0.58 
Leu 8.23 8.03 16.64 
Met 2.46 2,6 I 3.93 
Am 4.49 5.75 2.31 
Pro 5.20 4.84 I .96 
Gin 5.39 4,24 1.14 
Ar6 6.65 4.75 0.27 
Ser 7.40 6.41 5.58 
Thr 5.18 5.87 4.68 
Val 5.27 6.07 12.43 
Trp 1.06 2.31 2.20 
Tyr 2.75 4.55 3.13 
No. of peptides 34 20 127 
The total number of peptides used in the estimation is indicated at the 
bottom row. The 24 multi-spanning membrane proteins used in this 
analysis are listed below with protein name, PIR code, and regions of 
cytoplasmic or extracellular peptides: a region indicated in reverse 
order, e.g. 3 14-221 in the first protein below, represents an extracellu- 
lar peptidc from residues 22i to 314. and one in the normal order as 
340-887 represents a cytoplasmic peptide from residues 340 to 887. 
Pcptide regions horter than 50 residuesare not shown. Hydroxymeth- 
ylglutaryl-CoA reductase (RDHYE 314-221, 340-887) [39]; Na+/K+- 
transporting ATPase CL chain (PWSHNA l-93,148-288,347-784 [ 0]; 
myelin protcolipid protein (MPBOPL 150-97) [41]; B-2.adrenergic 
receptor (QRHYB? 221-274. 330-418) [42]; nicotinic acetylcholinc 
receptor CI chain (ACHUAI 230-21, 319-423) [43]; sodium channel 
protein (CHEE l-l 13.378-265,403~557.766-712, 1235-l 153, 1543- 
1475, 1568-1820)[44]; multidrug resistance protein I (DVHUl l-51, 
237-196, 778-832. 875-936) [4S]; inner membrane protein nraiF 
(MMECMF 276-92) [46]; virulence membrane protein p/toQ 
(VZEBPT 219-487) [47]; CITY polyprotein (VCLJSP 1-63,578-88)[48]; 
El membrane glycoprotein (MMIHIB 102-225) [49]; cytochrome c
oxidase polypeptide II (SO0106 297-130) [SO]; reaction center protein 
M chain (B251022-52)[17]; membrane protein patched (SO61 9 l-73, 
42693,5&S-676,966-700) [5 I]; potassium channel protein A (SO0479 
l-227, 479-616) 1521; follicle stimulating hormone receptor (JN0122 
631-695) [53]; glucose-transport protein (A27217 207-271) 1541; mus- 
cnrinic acetylcholinc receptor M2 (A27386 208-387) [55]; y-aminobu- 
tyric acidlbcnzodiazepine r ceptor (827142 245-26, 328-451) [56]; 
periphcrin (A34608 263-322, 283-345) [57]; dihydwphyridine recq- 
tor (A30063 I-51. 309-219,335-432.636-582. 662-799. 1066-I 118, 
1356-J 290) [SS]; glutamate receptor (SO7059 480-I 9, 633-805, 907- 
827) [59]; glycine receptor (A27141‘ 315-398) [60]; and steroid 17-a- 
monooxygenase (A30828 22-l 68, 507-l 87) [61,62], 
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more often on the cytoplasmic side. Therefore, the high 
content of Thr on the extracellular side cannot be ex- 
plained by glycosylation alone. The high content of Cys 
residues on the extracellular side may result from disul- 
fide bond formation. Basic residues (Arg, Lys) were 
frequently observed at the edge of the cytoplasmic side 
as stop-transfer signals [7,36-391, This may help to ex- 
plain why Arg and Lys are more abundant in cytoplas- 
mic peptides. 
The reason why such an imbalance of the amino acid 
composition exists between the cytoplasmic and ex- 
tracellular peptides is currently unexplained. One possi- 
ble reason is that some kind of restriction in the se- 
quence is required for transportation of a peptide chain 
through the lipid bilayer of the membrane. Nevcrthe- 
less, this study shows that it is possible to infer for 
membrane proteins which peptide portion flanking a 
transmembrane s gment is located on which side of the 
membrane. 
REFERENCES 
Dayhoff, M.O. (1976) Atlas of Protein Sequence and Structure, 
vol. 5, Suppl. 2, Nail. Biomed. Res. Foundation Silver Spring, 
Washington DC. 
Baker, WC,, George, D.G. and Hunt, L.T. (1990) Methods En- 
zymol, 183, 31-49. 
Nishikawa, K. and Ooi. T. (1982) J. Biochem. 91, 1821-1824. 
Nishikawa, K., Kubota. Y. and Ooi, T. (1983) J. Biochem. 94, 
997-1007. 
Nakashima, H., Nishikawa, K. and Ooi, T. (1986) J. Biochem. 
99, 153-162. 
Nakashima, H., Nishikawa, K. and Ooi, T. (1990) Proteins 8, 
173-178. 
von Heijne. G. and Gavel, Y. (1988) Eur. J. Biochcm. 174,671- 
678, 
Ohsuye, K., Kildno, K., Wada, Y., Fuchimura, K., Tanaka, 8. 
Mizuno. K, and Ma~suo, H. (198%) Biochem. Biophys. Res. Com- 
mun. 150, 1275-1281. 
Black, S.D. and Coon, M.J. (1982) J. Biol. Chcm. 257,5929-5938, 
Porter, T.D. and Kasper. C.B. (1985) Proc. Natl. Acad. Sci. USA 
82, 973-977. 
Fields, S., Winter, G. and Brownlee, G.G. (1981) Nature 290, 
213-217. 
[I21 Hoppe, J. and Sebald. W. (1984) Biochem. Biophys. Aaa 768, 
1-27. 
[I31 Noguchi, S., ?Iod:l, M., Takahashi, H., Kawakami. K., Ohta. T., 
Nagano. K., Hirose, T., Inayama, S., Kawamurd, M. and Numa, 
S. (1986) FEBS Lett. 196, 315-320, 
[I41 Boyd, A., Kendall, K. and Simon, M.I. (1983) Nature 301,623- 
626. 
[IS] Lamb, R-A., Zebedee, S.L. and Richardson, C.D. (1985) Cell 40, 
627633, 
[I61 Miller, V.L., Taylor, R.K. and Mekalanos, J.J. (1987) Cell 48, 
271-279. 
[I71 Deisenhohr, J., Epp, O., Miki, K., Huber, R. and Michel, H. 
(1985) Nature 318, 618624. 
[I81 Vtissin, H., Bremer, K-A,, Knust. E. and Campos-Ortega, J.A. 
(1987) EMBO J. 6,3431-3440, 
[19] Sprenyer, P., Stevens, L.M. and Nusslein-Volhard, C, (1989) 
Nature 338, 478-483. 
[20] Hibbs, M.L., Bonadonna, L., Scott, B.M., McKenzie, I.F.C. and 
Hogarth, P.M. (1988) Proc. Natl. Acad. Sci. USA 85.2240- 2244. 
[2l] Hatakcyama. M.. Tsudo, M., Minamoto. S., Kono. T,, Doi. T,. 
Miyata, T., Miyasaka, M. and Taniguchi. T. (1989) Science 244. 
551-556. 
[22] Crimaudo, C., Hortsch. M., Gausepohl. H. and Meyer, D.I. 
(1987) EMBO J. 6, 75-82. 
[23] Leung. D.W.. Spncer. S.A.. Cachianes, G., Hammonds, R-G,. 
Collins, C.. Henzel, W.J.. Barnard, R., Waters, M.J. and Wood. 
W.I. (1987) Nature 330, 537-543. 
[?4] Jones, N.H., Clabby, M.L., Dialynas, D.P., Huang, H..J.S.. 
Herzenberg, L.A. and Strominger, J.L. (1986) Nature 323,346- 
P51 
WI 
I271 
PI 
P91 
1301 
[311 
1321 
f”3:; 
1351 
‘r:q 
1381 
[391 
349. 
Dahms. N.M.. Lobel, P., Brcitmeyer, J.. Chirgwin. J.M, and 
Kornfeld, S. (1987) Cell 50. 181-192. 
Lobel, P., Dahms, N.M. and Komfeld, S. (1988) J. Biol. Chem. 
263, 2563-2570. 
Moos, M., Tacke, R., Scherer, H., Teplow, D., Frllh, K. and 
Schachner, M. (1988) Nature 334, 701-703. 
van Driel, I.R. and Ooding. J.W. (1987) J. Biol. Chem. 262, 
4882-4887. 
Yarden, Y., Eswbcdo, J.A., Kwng, W.-J., Yang-Fen& T.L., 
Daniel, 7.0.. Tremble. P.M., Chen, E,Y., Ando, M.E., Harkins, 
R.N.. Francke. U.. Fried, V-A., Ullrich, A. and Williams, L.T. 
(1986) Nature 323, 226-232. 
Kuhn, L.A. and Leigh Jr., J.S. (1985) B&him. Biophys. Acta 
828. 351-361. 
Deber. CM., Brandl, C.J.. Deber, R-B., Hsu, L.C. and Young, 
X.K. (1986) Arch. Biochcm. Biophys, 251. 68-76. 
Chou. P.Y. and Fasman, G.D. (1978) Annu. Rev. Biochcm. 47. 
251-276. 
Levitt, M, (1978) Biochemistry 17. 4277-4285. 
Baron, M,, Norman, D.G. and Campbell, I.D. (1991) Trends 
Biochem. Sci. 16, 13-17. 
Sabatini, D.D.. Krcibich, G., Morimoto, T. and Adcsnik. M. 
(1982) J. Cell Biol. 92, l-22. 
von Heijne, G. (1986) EMBO J. 5. 3021-3027. 
von Heijne, G. (1989) Nature 341.456-458. 
Hartmann, E.. Rapoport, T.A, and Lodish. H.F. (1989) Pm. 
Natl. Acad. Sci. USA 86, 5786-5790, 
Liscum, L., Finer-Moore. J., Stroud. R.M., Luskey, K.L., 
Brown, MS, and Goldstein, J.L. (1985) J. Biol. Chcm. 260,522- 
530. 
[40] Ovchinnikov, Yu.A., Arzamazova, N.M.. Arystarkliova, E.A.. 
Gevondyan. N.M.. Aldanova. N.A. and Mdyanov, N.N. (1987) 
FEBS Lett. 217.269-274. 
[41] Stoffel, W., Hillen, H. and Giersiefen, H. (1984) Proc. Natl. Acad. 
Sci. USA 81, 5012-5016. 
[42] Dohlman, H.G., Bouvier. M., Benovic, J.L., Caron, M.G. and 
Lefkowitz, R.J. (1987) J. Biol. Chem. 262, 14282-14288. 
[43] Noda. M., Furutani, Y., Takahashi. H.. Toyosato. M.. Tanabe, 
T.. Shimizu. S.. Kikvotani. S.. Kavano. T.. Hirose. T.. Inayama, 
[441 
1451 
PI 
[471 
t481 
1491 
I501 
1511 
S’and N&a, s, (1983) Nature 305,818823. - 
Noda, M., Shimizu. S.. Tanabe,T.,Takai, T., Kayano. T.. Ikeda, 
T., Takahashi. H., Nakayama, H., Kanaoka. Y., Minamino, N.. 
Kangawa, K., Matsuo. H.. Raftery. M.A., Hirose. T., lnayama, 
S., Hayashida. H.. Miyata, T. and Numa, S. (1984) Nature 3 12, 
121-127. 
Chcn, C., Chin, J.E., Ueda, K., Clark, D.P.. Pastan. I.. Gottes- 
man, M.M. and Roninson, LB. (1986) Cell 47, 381-389. 
Boyd, D., Manoil, C. and Beckwith, J. (1987) Proe. Natl. Aad. 
Sci. USA 84.8525-8529. 
Miller, S.I., Kukral. A.M. and Mekalanos. J.J. (1989) Proc. Natl. 
Acad. Sci. USA 86, 5054-5058. 
Fltigel, R.M.. Rethwilm, A,, Maurcr, B. and Darai. G. (1987) 
EMBO J. 6, 2077-2084. 
Machamer, C.E. and Rex. J.K. (1987) J. Cell Biol. 105. 1205- 
1214. 
Holm, L., Saraste, M. and Wikstr6m. 111. (1987) EMBO J. 6, 
28 19-2823. 
Nakano. Y., Gucrrero, I,. Hidalgo, A..Taylor. A., Whittle. J.R.S. 
145 
Volume 303, number 2,3 FENS LETTERS June 1992 
and Ingham, P,W. (1989) Nature 341, 508-513. 
1521 Pangs, O., Keeskcmethy, N., Muller, R,, Krah-Jentgcns, I . Bau- 
mann, A., Kilt& H.H., Canal, I., Liamazarcs. S, and Fetrus, A. 
(1988) EMBO J. 7, 1087-1096. 
[53] Mine&hi, T.. Nakamura, K., Takakura, Y., Ibuki, Y. and Iga. 
rashi, M. (1991) Biochem. Biophys. Res, Commun. 175, I l25- 
1130. 
1541 Mueckler, M., Caruso, C., Baldwin, !%A,, Panico. M,, Blench, I., 
Morris. H.R., Allard. W.J., Lienhard, G.E, and Lodish, H.E 
(1985) Science 229, 941-945. 
[55] Pcralta, E.G., Winslow, J.W.. Peterson, G.L.. Smith. D.H., 
Ashkenazi, A., Ramachandran, J., Schimcrlik. M.I. snd Capon, 
D. J, (1987) Science 236, 600-605, 
[56] Schofield, P.R.. Darlison, M.G.. Fujita, N., Burt, D.R., Stcphen- 
son, F.A.. Rodriguez, H., Rhee. L.M.. Ramuchandran. J., Reale, 
V., Glencorse, T.A., Sceburg, P.H. and Barnard, EA. (1987) 
Nature 328, 221-227. 
[571 Connell. G.J. and Molday. R.S. (1990) Biochemistry 29, 4691- 
4698, 
!SBI Tanabe, T.. Takeshima, H., Mikami, A,, Flockerzi, V., Taka- 
hashi, H., Kangawa, K., Kojima, M., Matsuo, H,, Hirose, T. and 
Numa, S. (1987) Nature 328, 313-318. 
[591 Hollmann, M., G’ShcaQeentield, A., Rogers, SW, and Heine- 
mann, S. (1989) Nature 342, 643-648. 
[601 Grenningloh, G., Rienitz, A., Schmitt, B., Methfessel, C.. Zensen. 
M,, Beyreuther. K., Gundelfinger, E.D. and Berz, H. (1987) Na- 
ture 328, 215-220. 
[611 Namiki, M., Kitamura, M., Buczko, E. and Dufau, M.L. (198B) 
Biochem. Biophys. Res. Commun. 157, 705-712. 
[62] Edwards, R.J., Murray, B.P., Singleton, A.M. and Boobis, A.R. 
(1991) Biochemistry 30, 71-76. 
146 
